Cite

HARVARD Citation

    Qu, X. et al. (2017). Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials. Cancer. 123 (13), pp. 2472-2481. [Online]. 
  
Back to record